You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

dalpiciclib

Showing 1 - 15 of 15
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer Trial in Wuhan (Adebrelimab, dalpiciclib)

Recruiting
  • Breast Cancer
  • Wuhan, Hubei, China
    Tongji Hospital Affiliated of Tongji Medical College Huazhong Un
Nov 20, 2023

Breast Cancer Trial in Shijiazhuang (Dalpiciclib, Aromatase inhibitor, Docetaxel injection)

Recruiting
  • Breast Cancer
  • Dalpiciclib
  • +4 more
  • Shijiazhuang, Hebei, China
    The Fourth Hospital of Hebei Medical University
Oct 25, 2023

Dalpiciclib in Hormone Receptor-positive Advanced Breast Cancer

Not yet recruiting
  • Breast Cancer
  • Dalpiciclib
  • (no location specified)
Oct 10, 2022

Breast Cancer Trial in Tianjin (Dalpiciclib, Pyrotinib, Fulvestrant)

Not yet recruiting
  • Breast Cancer
  • Dalpiciclib
  • +2 more
  • Tianjin, China
    Tianjin Cancer Hospital
Mar 28, 2023

Breast Cancer Trial in Shanghai (Dalpiciclib, Fulvestrant, Pertuzumab)

Active, not recruiting
  • Breast Cancer
  • Dalpiciclib
  • +3 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Oct 10, 2022

HR+/HER2- Advanced Breast Cancer Trial in Beijing (Dalpiciclib, Chidamide)

Not yet recruiting
  • HR+/HER2- Advanced Breast Cancer
  • Beijing, Beijing, China
    The Fifth Medical Center of PLA General Hospital
Oct 17, 2022

Solid Tumor Trial (Dalpiciclib)

Not yet recruiting
  • Solid Tumor
  • Dalpiciclib
  • (no location specified)
Aug 22, 2022

Breast Cancer Trial in Shenyang (Pyrotinib, Trastuzumab, Dalpiciclib)

Not yet recruiting
  • Breast Cancer
  • Shenyang, Liaoning, China
    Shengjing Hospital of China Medical University
Dec 2, 2022

Advanced/Metastatic Colorectal Cancer Trial in Guangzhou (Dalpiciclib, Oxaliplatin injection, Calcium folinate)

Not yet recruiting
  • Advanced/Metastatic Colorectal Cancer
  • Dalpiciclib
  • +3 more
  • Guangzhou, Guangdong, China
    Sixth Affiliated Hospital, Sun Yat-sen University
Jul 28, 2022

Metastatic Breast Cancer Trial in Guangzhou, Shantou (Mecapegfilgrastim, dalpiciclib, exemestane, fulvestrant, letrozole,

Not yet recruiting
  • Metastatic Breast Cancer
  • Guangzhou, Guangdong, China
  • +2 more
Jul 17, 2022

Breast Cancer Metastatic Cancer Trial in Shanghai (Apatinib, Dalpiciclib, Fulvestrant/AI)

Recruiting
  • Breast Cancer Metastatic Cancer
  • Shanghai, Shanghai, China
    Breast cancer institute of Fudan University Cancer Hospital
Feb 26, 2023

Breast Cancer Metastatic Cancer Trial in Shanghai (Fluzoparib, Dalpiciclib, Fulvestrant/AI)

Recruiting
  • Breast Cancer Metastatic Cancer
  • Shanghai, Shanghai, China
    Breast cancer institute of Fudan University Cancer Hospital
Feb 26, 2023

Metastatic Breast Cancer Trial in Shanghai (Trastuzumab, pyrotinib, Dalpiciclib)

Not yet recruiting
  • Metastatic Breast Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center Shanghai, China, 200032
Oct 11, 2022

Breast Tumor, Breast Cancer, Hormone Receptor Positive Tumor Trial in Shanghai (PIK3CA inhibitor, AKT inhibitor, Carrelizumab)

Recruiting
  • Breast Neoplasm
  • +4 more
  • PIK3CA inhibitor
  • +12 more
  • Shanghai, Shanghai, China
    Breast cancer institute of Fudan University Cancer Hospital
Jan 2, 2023

Breast Tumor, Breast Cancer, Breast Tumors Trial in Shanghai (Dalpiciclib, Pyrotinib, SHR-A1811)

Not yet recruiting
  • Breast Neoplasm
  • +9 more
  • Dalpiciclib
  • +15 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center Shanghai, China, 200032
Oct 13, 2022